Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Goeddel David V
Relationship:   10% Owner
City:   So. San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   9    
Direct Shares   21,008,913    

Indirect Shares

   32,725,451      
Direct Value   $107,224,205    

Indirect Value

   $145,808,454      
Total Shares   53,734,364      
Total Value   $253,032,660      


Immune Design Corp. $0 Gritstone Oncology, Inc. $2,316,030 Rapt Therapeutics, Inc. $22,803,513 Oric Pharmaceuticals, Inc. $0 Revolution Medicines, Inc. $82,104,662 Nurix Therapeutics, Inc. $0 Immune Design Corp. $0 Gritstone Oncology, Inc. $2,316,030 Rapt Therapeutics, Inc. $22,803,513 Oric Pharmaceuticals, Inc. $0 Revolution Medicines, Inc. $82,104,662 Nurix Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    63   
    4    

     Stock price went up :
    24   
    1    
     Stock price went down :
    39   
    3    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   -0.2%
 -73.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Immune Design Corp. IMDZ 10% Owner 2016-09-20 3,961,942 2014-07-29 0    Premium*  
            Gritstone Oncology, Inc. GRTS Managing Partner 2018-10-02 3,102,934 2018-10-02 0    Premium*  
            Ngm Biopharmaceuticals Inc NGM Director, 10% Owner 2024-04-05 0 2024-04-05 1,000    Premium*  
            Rapt Therapeutics, Inc. RAPT Managing Partner, 10% ... 2020-09-22 5,630,497 2019-11-04 195,401    Premium*  
            Oric Pharmaceuticals, Inc. ORIC Managing Partner, 10% ... 2020-04-28 4,768,181 0    Premium*  
            Revolution Medicines, Inc. RVMD 10% Owner 2020-11-16 2,151,026 2020-11-16 3,799,202    Premium*  
            Nurix Therapeutics, Inc. NRIX 10% Owner 2021-05-05 1,394,333 2021-05-05 1,420,954    Premium*  
            Tenaya Therapeutics, Inc. TNYA 2021-08-03 0 2024-02-12 22,999,565    Premium*  
            Effector Therapeutics Ord Shs EFTR 10% Owner 0 2021-08-25 4,309,329    Premium*  
* Premium Members only  

Records found :    145         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NGM Ngm Biopharmaceuticals In... Managing Partner   –       •       •   2020-09-01 4 B $17.64 $643,754 D/D 36,494 1,799,430 3.92 %
NGM Ngm Biopharmaceuticals In... Managing Partner   –       •       •   2020-09-02 4 B $17.67 $487,604 D/D 27,595 1,827,025 3.92 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-01-24 4 B $0.00 $0 I/I 250,000 8,250 2.17 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-01-25 4 B $0.00 $0 I/I 599,701 28,041 2.17 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-05-09 4 B $10.79 $897,699 I/I 83,175 30,786 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-05-10 4 B $11.36 $355,283 I/I 31,265 31,818 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-05-11 4 B $11.23 $935,354 I/I 83,175 34,563 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-05-12 4 B $11.62 $966,678 I/I 83,175 37,308 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-05-13 4 B $0.00 $0 I/I 129,365 41,577 2.17 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-05-16 4 B $12.90 $427,891 I/I 33,166 42,671 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-05-17 4 B $13.42 $1,194,779 I/I 89,049 45,610 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-05-18 4 B $13.20 $827,224 I/I 62,650 47,677 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-05-19 4 B $13.25 $273,922 I/I 20,666 48,359 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-05-20 4 B $13.48 $256,533 I/I 19,034 48,987 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-05-24 4 B $13.37 $238,325 I/I 17,828 49,575 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-05-25 4 B $13.43 $581,624 I/I 43,292 51,004 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-05-26 4 B $13.49 $272,582 I/I 20,201 51,671 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-05-27 4 B $13.45 $36,453 I/I 2,710 51,760 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-05-31 4 B $13.47 $832,267 I/I 61,806 53,800 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-06-01 4 B $13.45 $1,237,400 I/I 92,000 56,836 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-06-02 4 B $13.03 $445,739 I/I 34,200 57,965 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-06-09 4 B $13.50 $13,286,174 I/I 984,161 90,442 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-10-17 4 B $3.18 $159,140 D/D 50,000 130,000 3.92 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-10-18 4 B $3.79 $303,256 I/I 80,000 190,000 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-10-25 4 B $4.75 $242,387 I/I 51,046 51,046 2.25 %
  145  Records found
  1   2   3   4  5   6      
  Page 4 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us